The FDA Law Blog

DECEMBER 8, 2022

Food and Drug Administration (FDA) issued two guidance documents, one draft and one final, on food allergen labeling requirements. 1, 2023; The applicability of food allergen labeling requirements to specific products (e.g., 1, 2023; The applicability of food allergen labeling requirements to specific products (e.g.,

Documentation 59

Documentation Labelling FDA Packaging 59

European Pharmaceutical Review

AUGUST 23, 2022

A study of the causes of warning letters issued by the US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiological Health (CDRH) between 2010 and 2020 revealed that poor current good manufacturing practice (cGMP) compliance and misbranding were the most common citations.

FDA 105

FDA Documentation Packaging Labelling 105

European Pharmaceutical Review

JANUARY 25, 2024

Draft guidance published by the US Food and Drug Administration (FDA) in December 2023, discussed quality considerations for topical ophthalmic drug products, including key considerations for extractables and leachables (E&L) testing. Ophthalmic drug products should be evaluated for extractables and leachables, FDA asserted.

FDA 98

FDA Documentation Method Validation Packaging 98

STAT

OCTOBER 19, 2022

After years of deliberation, the FDA recently announced a new set of rules it proposes to regulate claims on food packaging that a product is “healthy.” ” The most basic rule: the product must actually contain food, not just ingredients. Read the rest…

Packaging 98

Packaging Labelling FDA 98

Roots Analysis

APRIL 20, 2022

On an average, around 50 drugs are approved by the US Food and Drug Administration (US FDA) annually. This continuously growing pipeline of pharmaceutical drug products has inadvertently led to an increase in the demand for their associated primary packaging and Secondary Packaging solutions. . trillion in 2023.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Labelling 52

The FDA Law Blog

FEBRUARY 21, 2024

Mullen — More than five years after FDA first announced its plan to harmonize 21 CFR Part 820 with ISO 13485, on February 2, 2024, FDA finally issued the Quality Management System Regulation (QMSR) Final Rule. FDA further retained some definitions in the QSMR. Notably, Part 820 will look different. Revised § 820.3

FDA 59

FDA Labelling Packaging Documentation 59

Roots Analysis

AUGUST 26, 2024

In today’s global landscape, sustainability has emerged as a pivotal concern across various sectors including the pharmaceutical packaging industry. What is Sustainable Packaging / Green Packaging? The following figure presents the raw materials used by the sustainable packaging companies.

Packaging 40

Packaging Pharmaceutical Companies Pharmaceutical Companies Labelling 40

Pharmaceutical Technology

APRIL 26, 2023

Packaging plays a critical part in the pharmaceuticals and medical devices industries and is developed with its own set of security standards for the safety of consumers. The role of primary packaging has extended beyond the primary objectives of sterility, physical and chemical protection, and security.

Packaging 52

Packaging Documentation Communication Labelling 52

The FDA Law Blog

AUGUST 17, 2023

FDA-2023-P-0313 and FDA-2023-P-0344 ) regarding its product Hetlioz (tasimelteon). Vanda requested that FDA revoke the approval of Apotex’s and Teva’s generic versions of Hetlioz on the grounds that the generic tasimelteon products did not meet the statutory “same labeling” requirement for generic drugs found in 21 U.S.C. §

Labelling 40

Labelling FDA Packaging 40

The FDA Law Blog

JULY 10, 2023

After a firm submits a 510(k) to FDA, FDA will request still more information after a first-pass review. According to the 2 nd Quarter FY2023 MDUFA V Performance Report , FDA issued a request for additional information (AI request) on the first FDA review cycle for 63% to 68% of 510(k)s submitted in FY2018 to FY2022.

FDA 75

FDA Documentation Packaging Communication 75

The FDA Law Blog

SEPTEMBER 29, 2022

The statute itself – the National Bioengineered Food Disclosure Standard – requires use of one of three forms of disclosure: on-package text, a symbol, or an electronic or digital link. Thus, the Court concluded that addition of the standalone text message disclosure options was inconsistent with the statute’s mandate.

Labelling 59

Labelling Packaging 59

The FDA Law Blog

MAY 4, 2025

DEA seized five packages in Eagle Pass, Texas, identifying IMC Pro as the shipper containing 26.4 IMC Pro agreed to provide the Chinese companies with access to the shipping companys accounts for common carriers to generate domestic shipping labels for goods and products the Chinese companies sold or manufactured.

Controlled Substances 52

Controlled Substances Packaging Labelling 52

The FDA Law Blog

NOVEMBER 14, 2022

2022, FDA published a draft guidance on FDA’s implementation of the Over-the-Counter Monograph Drug User Fee Program (OMUFA). FDA is authorized to charge an annual facility fee for OTC monograph drug facilities. FDA will not refund any fees that have been incurred already). By Riëtte van Laack & Deborah L.

FDA 52

FDA Packaging Labelling Dosage 52

Pharmaceutical Technology

APRIL 14, 2023

The US Food and Drug Administration (FDA) has rejected Eli Lilly’s biologic licence application (BLA) for the ulcerative colitis (UC) drug mirikizumab over manufacturing concerns. No concerns related to the clinical data package, safety or the medicine label. The regulator has issued a complete response letter.

FDA 52

FDA Packaging Labelling 52

The FDA Law Blog

MARCH 27, 2023

Such codes need to be placed on device labels and packages to allow devices to be easily identified and tracked throughout their lifecycle, except where the rule provided for an exception or alternative. Devices can have both a UPC code and a UDI on their label and package. Most of the compliance dates have been passed.

Labelling 45

Labelling Packaging FDA Documentation 45

The FDA Law Blog

JUNE 26, 2024

Lenz, Principal Medical Device Regulation Expert — FDA recently released a new eSTAR template for device pre-submissions and 513(g) Requests for Information, referred to as PreSTAR. A pre-submission provides the submitter an opportunity to obtain FDA feedback prior to a planned medical device premarket submission.

FDA 98

FDA Labelling Packaging 98

The FDA Law Blog

JULY 22, 2024

FDA Law Blog readers receive a 10% discount off the tuition fee (promo code D10-999-FDA25 ). s John W.M. Claud will be speaking at the conference in a session titled “Crafting Your Safety Blueprint for Adverse Events and Recalls under MoCRA.” You can register for the conference here.

Packaging 59

Packaging Labelling FDA 59

The Checkup by Singlecare

JULY 22, 2024

It can also treat parasitic infections, like giardia, and is frequently used off-label (for a non-FDA-approved use) to help treat Crohn’s disease, bite wounds, and oral infections. Be sure to check food labels carefully for either of these ingredients. What should you eat while taking metronidazole?

Labelling 105

Labelling Packaging FDA 105

pharmaphorum

OCTOBER 1, 2020

Shares in US biotech CTI BioPharma have shot up after the FDA agreed to an accelerated review early next year of its lead drug pacritinib for low blood platelets (thrombocytopenia) caused by myelofibrosis. The post CTI wins over FDA to claim early review of myelofibrosis drug appeared first on. after the announcement.

FDA 52

FDA Packaging Labelling 52

The FDA Law Blog

OCTOBER 5, 2022

By Riëtte van Laack — On September 28, 2022, FDA announced the availability of the proposed rule for the implied nutrient content claim “healthy.” The term healthy, as an implied nutrient claim, was first defined by FDA in 1994. FDA also announced it would be re-evaluating the regulatory criteria for use of the “healthy” claim.

FDA 52

FDA Labelling Packaging Documentation 52

Pharmaceutical Technology

APRIL 21, 2023

On 14 April, the FDA rejected Lilly’s biologic licence application (BLA) for their anti-interleukin (IL)-23, mirikizumab, which is in development for the treatment of ulcerative colitis (UC). The recent setback dents mirikizumab’s chances to be the first among the IL-23 inhibitors to launch in the US for UC.

FDA 52

FDA Packaging Labelling 52

The Checkup by Singlecare

JUNE 17, 2024

It’s also can be used off-label to treat morning sickness during pregnancy. Zofran vs. ondansetron The FDA withdrew Zofran oral dissolving tablets (ODT) from the market in 2023, but not due to safety or effectiveness; instead, the decision was related to packaging concerns, says Dr. Glatter. Consult a healthcare professional.

Chemotherapy 105

Chemotherapy Dosage Packaging Hospitals 105

The FDA Law Blog

SEPTEMBER 6, 2023

Food and Drug Administration – labeled an “Official Action Indicated” classification – is generally devastating for the facility, not least because it can stall FDA approval of applications to market drugs manufactured at the facility. And the Guidance may be used as leverage to secure action from FDA on a meeting request.

FDA 45

FDA Packaging Documentation Labelling 45

Pharma Marketing Network

AUGUST 9, 2023

It’s crucial for marketing teams to stay informed about the latest guidelines, policies, and updates from regulatory bodies such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in the European Union. Keep thorough records of approvals for future reference.

Packaging 52

Packaging Labelling Communication Pharmaceutical Companies 52

The Checkup by Singlecare

MARCH 22, 2023

We have a regulator called Health Canada, similar to the Food and Drug Administration (FDA), which works to ensure the safety of our drugs,” Tadrous says. The FDA allows customers to purchase drugs from Canadian online pharmacies and have them shipped to the U.S. If you don’t live near the border between the U.S. Are not licensed.

Health and Personal Care Stores 105

Health and Personal Care Stores Controlled Substances Dosage FDA 105

The FDA Law Blog

JUNE 12, 2023

By Riëtte van Laack — FDA regulates pet food similar to other animal foods. The Federal Food, Drug, and Cosmetic Act (FDC Act) requires that all animal foods, like human foods, be safe to eat, produced under sanitary conditions, contain no harmful substances, and be truthfully labeled.

Labelling 45

Labelling FDA Packaging 45

The Checkup by Singlecare

AUGUST 8, 2024

She also explains that “Zyrtec’s use for dogs is ‘ off-label.'” Check the drug’s packaging and label carefully before giving it to your pet. The FDA says Zyrtec’s effects typically last around 24 hours for humans, and studies show that its elimination half-life is around 8.3

Dosage 96

Dosage Labelling Packaging Immunization 96

The Checkup by Singlecare

JANUARY 4, 2024

Always follow the directions on the packaging or consult a healthcare professional if you have concerns about the appropriate dosage. In addition, the FDA label for the nighttime forms of Mucinex containing acetaminophen recommends avoiding three or more drinks per day.

Immunization 102

Immunization Labelling Dosage Medication Labelling 102

The People's Pharmacy

JUNE 12, 2023

If a patient wants to report an adverse reaction to the FDA, they need to fill out Form 3500B. It is rare for pharmacies to put the expiration date on the label if they transfer the pills from the manufacturer’s original container. After all, computers easily generate a date one year from the dispensing day when printing the label.

Labelling 62

Labelling Mail-Order Pharmacies Adverse Reactions FDA 62

The Checkup by Singlecare

DECEMBER 29, 2023

Because Zyrtec causes sleepiness, the most concerning drug interactions involve drugs that also cause sedation, such as: Other antihistamines Tranquilizers Opioids Benzodiazepines Gabapentin General anesthetics Alcohol Cannabis Safety measures while using Zyrtec What are the FDA warnings about Zyrtec? Who should never take Zyrtec?

Packaging 93

Packaging FDA Labelling Dosage 93

The Checkup by Singlecare

DECEMBER 2, 2024

Your Zyrtec will expire, and the Food and Drug Administration (FDA) requires the manufacturer to include the expiration date on the product. Drugs are chemical compounds that can break down over time, and the FDA wants to ensure that consumers are taking safe and effective medication. Knowing more can help you better prepare.

Compounding 52

Compounding Labelling FDA Packaging 52

The Checkup by Singlecare

MARCH 21, 2024

Nonetheless, healthcare providers may prescribe it off-label for weight loss. Its active ingredient, semaglutide, is FDA approved for weight loss under the brand name Wegovy , which has a dosing progression of 0.25 Ozempic can be effective across all dosages for weight loss, but higher doses saw better results. mg, 1 mg, 1.7

Insurance Coverage 98

Insurance Coverage Insurance Dosage Mail-Order Pharmacies 98

Pharmaceutical Technology

JUNE 20, 2023

UK-based biotech F2G was dealt a blow as the US’ FDA issued a complete response letter rejecting its latest new drug application (NDA). F2G claimed in a June statement that the FDA requested additional data and analysis that extended beyond the current review period.

FDA 52

FDA Packaging Labelling Communication 52

pharmaphorum

JANUARY 30, 2023

For its part, the US Food and Drug Administration (FDA) posted its drug shortage list , which contains various formulations of amoxicillin that are limited in supply. Looking to the long-term However, despite the issue being exacerbated by geopolitical factors, the challenge is a broad one that requires a long-term strategy to navigate.

Generic Medicine 104

Generic Medicine Packaging FDA Labelling 104

The Checkup by Singlecare

MAY 12, 2025

Containing the active ingredient polyethylene glycol 3350 (PEG 3350), MiraLax is FDA approved to treat occasional constipation in adults. Follow the dosing instructions on the package and be patient. MiraLax is a popular brand-name, over-the-counter (OTC) laxative that helps relieve constipation.

Packaging 66

Packaging Labelling FDA 66

The Checkup by Singlecare

JULY 30, 2024

Food and Drug Administration ( FDA ) to treat pain and fever. Zyrtec (cetirizine) is an antihistamine approved by the FDA to treat allergies with respiratory symptoms, like runny nose, sneezing, watery eyes, itchy eyes, and itching in the nose and throat. Always read labels and instructions carefully.

Packaging 52

Packaging Labelling Dosage FDA 52

Pharma Marketing Network

AUGUST 9, 2023

It’s crucial for marketing teams to stay informed about the latest guidelines, policies, and updates from regulatory bodies such as the Food and Drug Administration (FDA) in the United States or the European Medicines Agency (EMA) in the European Union. Keep thorough records of approvals for future reference.

Packaging 40

Packaging Labelling Communication Pharmaceutical Companies 40